CASSAVA SCIENCES INC.
25.53
08-نوفمبر-24 09:58:58
15 متأخرة بدقائق
الأسهم
+0.19
+0.75%
نطاق اليوم
24.75 - 26.05
ISIN
N/A
المصدر
NASDAQ
-
21 يونيو 2021 15:10:00 بحسب Nasdaq GlobeNewswire
-
21 يونيو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference
17 يونيو 2021 15:01:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
14 يونيو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
24 مايو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease
10 مايو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
27 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
26 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
21 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights
23 مارس 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
09 مارس 2021 08:00:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
08 مارس 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
23 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
22 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering
12 فبراير 2021 16:08:17 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
10 فبراير 2021 05:15:06 بحسب Nasdaq GlobeNewswire
-
08 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
02 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 يناير 2021 07:30:00 بحسب Nasdaq GlobeNewswire